Molina Healthcare (NYSE:MOH – Free Report) had its target price decreased by Truist Financial from $250.00 to $225.00 in a research report report published on Friday,Benzinga reports. Truist Financial currently has a hold rating on the stock.
A number of other equities analysts have also issued reports on MOH. Royal Bank Of Canada decreased their price objective on Molina Healthcare from $248.00 to $218.00 and set a “sector perform” rating for the company in a report on Friday. Bank of America raised shares of Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price target for the company in a research note on Wednesday, April 29th. UBS Group increased their price objective on shares of Molina Healthcare from $180.00 to $202.00 and gave the company a “neutral” rating in a report on Friday, May 22nd. Zacks Research raised Molina Healthcare from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th. Finally, Mizuho set a $215.00 price target on Molina Healthcare in a research report on Monday, June 8th. Three research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $203.38.
Read Our Latest Research Report on MOH
Molina Healthcare Trading Down 1.3%
Molina Healthcare (NYSE:MOH – Get Free Report) last announced its quarterly earnings results on Wednesday, July 22nd. The company reported $1.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.12. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.73%. The company had revenue of $10.87 billion during the quarter, compared to the consensus estimate of $10.83 billion. During the same quarter in the previous year, the company posted $5.48 earnings per share. The company’s revenue for the quarter was down 4.8% compared to the same quarter last year. Equities research analysts predict that Molina Healthcare will post 5.25 EPS for the current year.
Insider Transactions at Molina Healthcare
In other Molina Healthcare news, insider Jeff D. Barlow sold 17,811 shares of the stock in a transaction on Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the transaction, the insider directly owned 67,175 shares of the company’s stock, valued at $12,502,611. This represents a 20.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Maurice Hebert sold 600 shares of the firm’s stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the transaction, the chief accounting officer directly owned 12,815 shares in the company, valued at $2,454,713.25. The trade was a 4.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 1.44% of the company’s stock.
Hedge Funds Weigh In On Molina Healthcare
Several large investors have recently made changes to their positions in MOH. 7G Capital Management LLC bought a new stake in shares of Molina Healthcare in the fourth quarter valued at about $1,735,000. BNP Paribas Financial Markets grew its position in Molina Healthcare by 63.0% during the fourth quarter. BNP Paribas Financial Markets now owns 439,371 shares of the company’s stock worth $76,248,000 after buying an additional 169,739 shares in the last quarter. Allspring Global Investments Holdings LLC increased its stake in Molina Healthcare by 27.4% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 38,913 shares of the company’s stock valued at $6,944,000 after acquiring an additional 8,381 shares during the period. SG Americas Securities LLC increased its stake in Molina Healthcare by 923.3% during the fourth quarter. SG Americas Securities LLC now owns 87,220 shares of the company’s stock valued at $15,136,000 after acquiring an additional 78,697 shares during the period. Finally, M&T Bank Corp raised its holdings in Molina Healthcare by 451.1% in the 4th quarter. M&T Bank Corp now owns 42,455 shares of the company’s stock valued at $7,368,000 after acquiring an additional 34,751 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.
Key Molina Healthcare News
Here are the key news stories impacting Molina Healthcare this week:
- Positive Sentiment: Molina Healthcare beat Q2 earnings expectations with EPS of $1.51, and lower operating expenses helped offset weaker premium revenue and softer investment income. The company also raised its 2026 EPS outlook, which supports the long-term earnings case. Article Title
- Positive Sentiment: Analysts still see some upside from current levels despite recent weakness, with Truist and RBC both saying the stock could rise into the low-to-mid $200s. Article Title
- Neutral Sentiment: Wall Street’s consensus recommendation remains “Hold,” suggesting analysts are not turning bullish yet, but are also not broadly negative on the name. Article Title
- Negative Sentiment: Revenue and membership trends remain a concern, and multiple reports said investors were disappointed by weaker premium revenue and softer guidance even after the earnings beat. Article Title
- Negative Sentiment: Market reaction has been negative because Molina warned about a smaller Obamacare footprint and ongoing pressure in its Medicaid/ACA businesses, which outweighed the earnings beat. Article Title
Molina Healthcare Company Profile
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Recommended Stories
- Five stocks we like better than Molina Healthcare
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
